InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Friberg Gregory R. Officer active across 1 company, notably Biomarin Pharmaceutical INC. Aggregated, 6 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €323k. History available since 30 September 2024. The latest transaction was filed on 16 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Friberg Gregory R is a declarant linked to Biomarin Pharmaceutical INC. Across 6 filings on record, the 6 sampled filings run from 2024-10-01 to 2026-03-18, with EUR 323260 of sales and EUR 0 of purchases. No primary role is provided, although the company listed him as EVP, Chief R&D Officer.